Form 4: Director Scott Stephen Receives cbdMD Equity Grant

Director Scott Stephen was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Summary

• Director Scott Stephen acquired 1,572 restricted stock units (RSUs) of cbdMD, Inc. common stock.
• The grant was issued as compensation for board services under the company's equity compensation plan.
• Each RSU represents a contingent right to receive one share of common stock.
• The total beneficial ownership for the director following this transaction is 4,412 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• The issuance of additional equity results in minor dilution to existing shareholders.

Risks

• The value of the equity grant is subject to the market performance of cbdMD common stock.

Future Outlook

The RSUs will vest in four equal quarterly installments starting June 30, 2026, and concluding March 31, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice designed to incentivize long-term oversight and strategic alignment in the consumer wellness and CBD sector.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices for small-cap publicly traded companies.
• The vesting schedule of one year is standard for director equity grants in the industry.

Corporate Governance

Stakeholder Impact

• Shareholders experience minor dilution from the issuance of new equity.

Next Steps

• Vesting of the first tranche of RSUs on June 30, 2026.

Key Dates

Keywords

cbdMD, YCBD, Form 4, Insider Trading, Equity Compensation, Director Compensation